#abbvie — Public Fediverse posts

🔹Welt-Hepatitis-Tag: Kostenlose Hepatitis-C-Testaktion im Kontaktladen der Drogenberatung🔹

Anlässlich des Welt-Hepatitis-Tags am gestrigen Dienstag, 28. Juli, fand im Kontaktladen der Abteilung Drogenberatung und Prävention der Stadt Ludwigshafen, eine kostenlose Testaktion auf Hepatitis-C-Viren statt. Unterstützt wurde die Aktion durch das Biopharmaunternehmen #AbbVie.

🔹Welt-Hepatitis-Tag: Kostenlose Hepatitis-C-Testaktion im Kontaktladen der Drogenberatung🔹

Anlässlich des Welt-Hepatitis-Tags am gestrigen Dienstag, 28. Juli, fand im Kontaktladen der Abteilung Drogenberatung und Prävention der Stadt Ludwigshafen, eine kostenlose Testaktion auf Hepatitis-C-Viren statt. Unterstützt wurde die Aktion durch das Biopharmaunternehmen #AbbVie.

US stocks drift near their records after oil prices fall

NEW YORK (AP) — U.S. stocks are drifting near their records in mixed trading Monday after trading resumed…
#NewsBeep #News #BreakingNews #AbbVie #ApogeeTherapeutics #breakingnews #Business #CMEGroup #energymarkets #FederalReserveSystem #financialmarkets #Generalnews #Inc. #Iran #iranwar #KeirStarmer #Oilandgasindustry #SpaceX #Stocksandbonds #Worldnews
https://www.newsbeep.com/605493/

US stocks drift near their records after oil prices fall

NEW YORK (AP) — U.S. stocks are drifting near their records in mixed trading Monday after trading resumed…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Business #AbbVie #ApogeeTherapeutics #CMEGroup #energymarkets #FederalReserveSystem #Financialmarkets #Generalnews #Inc. #iran #Iranwar #KeirStarmer #oilandgasindustry #spaceX #Stocksandbonds #Worldnews
https://www.newsbeep.com/us/719474/

Analysis: Market Outlook for AbbVie Following Recent Earnings Performance

📰 Original title: Watch: Why Investors Are Still Worried About AbbVie

🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️

View full AI summary: https://killbait.com/en/analysis-market-outlook-for-abbvie-following-recent-earnings-performance/?redirpost=aefe28ea-2bb7-4a5d-86e4-14d8cd4103cd&utm_source=mastodon_world&utm_medium=social&utm_campaign=yOAxulYDJiR0231eonVH5fVZzdi42_IDdV5yvxQXYkQ

#business #abbvie #inves...

Analysis: Market Outlook for AbbVie Following Recent Earnings Performance

📰 Original title: Watch: Why Investors Are Still Worried About AbbVie

🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️

View full AI summary: https://killbait.com/en/analysis-market-outlook-for-abbvie-following-recent-earnings-performance/?redirpost=aefe28ea-2bb7-4a5d-86e4-14d8cd4103cd&utm_source=mastodon_social&utm_medium=social&utm_campaign=tawC1tPUo4nO8gfV507Ysi8dz02kz5dW5yXCkRHz8-k

#business #abbvie #inve...

Condamné à 850 000 €, le labo Abbvie paie (enfin) pour sa gestion opaque d’une pénurie critique. #medicament #AbbVie
https://www.lesmotsontunsens.com/penurie-de-medicaments-un-laboratoire-enfin-condamne/

#Paris #Agriculture Fair moo-ves forward without the
https://kensbookinfo.blogspot.com/p/world-capitals.html#Paris

#Trump’s moral flexibility on #Iran isn’t an asset —
https://kensbookinfo.blogspot.com/p/politics.html#14

#Trump's new tariff comes into effect at lower than
https://kensbookinfo.blogspot.com/p/canada.html#14

#AbbVie Invests $380M to Expand #Illinois #Manufacturing
https://kensbookinfo.blogspot.com/p/business.html#55

#Kuwait dressed in national colors as citizens celebrate
https://kensbookinfo.blogspot.com/p/world-capitals.html#KuwaitCity

#Europe’s War on Digital Speech
https://kensbookinfo.blogspot.com/p/politics.html#29

#Paris #Agriculture Fair moo-ves forward without the
https://kensbookinfo.blogspot.com/p/world-capitals.html#Paris

#Trump’s moral flexibility on #Iran isn’t an asset —
https://kensbookinfo.blogspot.com/p/politics.html#14

#Trump's new tariff comes into effect at lower than
https://kensbookinfo.blogspot.com/p/canada.html#14

#AbbVie Invests $380M to Expand #Illinois #Manufacturing
https://kensbookinfo.blogspot.com/p/business.html#55

#Kuwait dressed in national colors as citizens celebrate
https://kensbookinfo.blogspot.com/p/world-capitals.html#KuwaitCity

#Europe’s War on Digital Speech
https://kensbookinfo.blogspot.com/p/politics.html#29

#Newteam takes on famous Lomax building where Oasis
https://kensbookinfo.blogspot.com/p/uk.html#lpool_echo

#Paris #Agriculture Fair moo-ves forward without the
https://kensbookinfo.blogspot.com/p/world-capitals.html#Paris

#Trump’s moral flexibility on #Iran isn’t an asset —
https://kensbookinfo.blogspot.com/p/politics.html#14

#Trump's new tariff comes into effect at lower than
https://kensbookinfo.blogspot.com/p/canada.html#14

#AbbVie Invests $380M to Expand #Illinois #Manufacturing
https://kensbookinfo.blogspot.com/p/business.html#55

#Kuwait dressed in national colors as citizens celebrate
https://kensbookinfo.blogspot.com/p/world-capitals.html#KuwaitCity

¿Por qué AbbVie prevé ganancias récord en 2026 gracias a la inmunología? La farmacéutica supera las expectativas y anticipa un crecimiento sostenido impulsado por nuevos medicamentos https://sagaroja.com/es/blog/empresas/abbvie-ganancias-inmunologia-2026 #Abbvie #Farmacuticas #Inmunologa

Bloomberg: #Alphabet #shares rally 6% in early trading as the company's strength in #search #advertising helped profit beat estimates. #AbbVie, #Colgate-Palmolive and #Schlumberger are slated to report later. #Stocks and the dollar edge higher. #markets

5 neuro data readouts to watch in the second half of 2024 — GSK moves to new HQ in return to central London — AbbVie led the way in paying doctors to pitch its drugs last year —http://bit.ly/w28kSd #clinicaltrials #neurology #gsk #london #abbvie #physicians #physicianpayments #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

AbbVie's tight grip on Humira market raises concerns about biosimilars—As biotech recovers, venture firms’ preferences appear to shift — Boehringer, Zealand heat up MASH race with strong phase II data—http://bit.ly/w28kSd #abbvie #humira #biosimilars #funding #mash #nash #boehringeringelheim #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

AbbVie (#ABBV) reported an actual EPS of $2.31, slightly higher than the forecasted $2.27. Additionally, its revenue beat expectations, with actual revenue at $12.31 billion compared to the forecasted $11.93 billion. #AbbVie #earnings

Patients in England to be offered daily pill that can halve migraine frequency | National Institute for Health and Care Excellence | The Guardian
https://www.theguardian.com/society/2024/apr/11/patients-in-england-to-be-offered-daily-pill-that-can-halve-migraine-frequency

#Migraine
#PillForMigraines
#MigrainePrevention
#NHSApprovedMedicine
#NICE
#NICEApproved
#Atogepant
#Aquipta
#AbbVie
#CalcitoninGeneRelatedPeptide
#CGRP
#ChronicMigraine
#EpisodicMigraine
#MigraineTrust
#ScottishMedicinesConsortium

Patients in England to be offered daily pill that can halve migraine frequency | National Institute for Health and Care Excellence | The Guardian
https://www.theguardian.com/society/2024/apr/11/patients-in-england-to-be-offered-daily-pill-that-can-halve-migraine-frequency

#Migraine
#PillForMigraines
#MigrainePrevention
#NHSApprovedMedicine
#NICE
#NICEApproved
#Atogepant
#Aquipta
#AbbVie
#CalcitoninGeneRelatedPeptide
#CGRP
#ChronicMigraine
#EpisodicMigraine
#MigraineTrust
#ScottishMedicinesConsortium

Strong demand for Botox, generating $1.49 billion in quarterly revenue, persists despite intense competition. AbbVie's 2024 earnings per share forecast falls in the range of $11.05 - $11.25 billion, aligning with analyst estimates at the upper end of this range, specifically at $11.24. #AbbVie #FinancialResults #EarningsReport #Humira #ImmunologyProducts #Botox #RevenueForecast #2024Projection #MarketExpectations

The negative outlook stemming from CVS Health's decision to delist Humira poses a challenge, but AbbVie aims to counter the lost revenue with new immunology products Skyrizi and Rinvoq. In its 2027 projection, AbbVie raised the revenue forecast for these drugs from $21 billion to $27 billion.#AbbVie #FinancialResults #EarningsReport #Humira #ImmunologyProducts #Botox #RevenueForecast #2024Projection #MarketExpectations

AbbVie reported robust financial results, with earnings reaching $2.79 per share and revenue totaling $14.3 billion. This surpassed market expectations of $2.77 per share and $14.01 billion in revenue. Despite increased competition impacting Humira, one of the company's leading drugs, leading to a 41% YoY decline in Q4 sales to $3.30 billion, it still exceeded analyst estimates of $3.28 billion. #AbbVie #FinancialResults #EarningsReport #Humira #ImmunologyProducts #Botox #2024Projection

How a #Drug Company Made $114 Billion by Gaming the US #Patent System
Over the past 20 years, #AbbVie and its former parent company increased #Humira’s price about 30 times, most recently by 8% this month over 60% total to over $80,000 a year!
https://nyti.ms/3HAC7Lr #healthcar

Talk about the tail wagging the dog: #AbbVie is leaving both PhRMA and BIO because "there was...frustration that AbbVie’s vigorous #patent battles could spill over and damage the industry’s overall image." Man, when the trade orgs won't go to bat for you 🤣
https://www.statnews.com/2022/12/15/abbvie-exits-major-pharmaceutical-industry-lobbying-groups #pharma

What top VCs look for in women’s fertility startups - A number of promising women’s health tech companies have popped up in the last few years, from ferti... more: http://feedproxy.google.com/~r/Techcrunch/~3/LXFLZqm6zm4/ #nationalinstituteofhealth #artificialintelligence #femalefoundersfund #reproductivehealth #medicaltechnology #chronicdisease #pharmaceutical #venturecapital #unitedstates #womenshealth #healthcare #startups #biotech #science #femtech #sequoia #health #abbvie #apps